As Delaware marked its third official Rare Disease Day on Feb. 28, it’s important to recognize both the impact of rare conditions on our communities and the need to take action for patients and families. Though each rare condition affects a relatively small number of people, their collective reach is staggering; according to the National Institutes of Health, 25 million to 30 million Americans live with one of the 7,000 diseases that fall under this label.
On an individual level, these illnesses take a significant physical, emotional and financial toll on patients and their families. The particular difficulty of finding resources, support groups and treatment for these uncommon conditions places an outsize burden on those affected, including many Delawareans.
Several Delaware residents impacted by rare diseases have stepped forward to share their stories in recent years, from leading health care advocate Irfan Patel to baseball enthusiast Dawson Johnson and 9-year-old Cassie DeChene. The experiences of these individuals and many others testify to their resilience, but they also reveal a common theme of uncertainty and difficulty finding support.
Diagnostic ambiguity, insurance holdups and a paucity of specialized treatments affect families in Delaware and across the nation. Most frustratingly, the very nature of rare diseases means that individuals and caregivers must often fend for themselves with little external support, and the unique challenges presented by rare conditions receive disproportionately little attention due to a lack of awareness.
Though rare disorders may not be as visible as other health care problems are, the plight of those affected — the child thrust into a hospital environment, the families navigating appeals with insurance — remains as significant as anybody else’s, and these people deserve the same recognition as those fighting more common conditions do.
Delaware has made significant progress to address rare-disease policy in recent years. Senate Bill 55 established the Rare Disease Advisory Council in 2023, and the legislature officially recognized Rare Disease Day in 2024.
However, much still remains to be done.
As of 2026, Delaware lacks exact statistics to quantify the incidence of rare diseases. The average time and barriers to diagnosis, access to care, impacts on quality of life, economic hardships and caregiver strain remain unmeasured in Delaware, precluding attempts at facts-based, community-oriented action. To better understand and appreciate Delawareans’ needs, policymakers and the state Department of Health and Social Services should consider leveraging sources like the Delaware Health Information Network or implementing a targeted statewide survey.
The state must also reckon with public health policy and insurance to expand access to health care diagnostics. Statistics from the National Organization for Rare Disorders indicate that 28% of individuals with rare diseases do not receive correct medical determinations until more than seven years after their symptoms begin. This complex and costly odyssey places emotional strain upon families who must contend with doubt and ambiguity before even beginning to pursue treatment.
Of particular importance to this issue is Delaware’s statewide newborn-screening program, which currently tests for 48 genetic disorders at birth. Early diagnoses allow treatments that greatly improve individual outcomes, but Delaware’s testing panel has yet to cover every condition recommended by the national secretary of health and human services.
When these disorders go undiagnosed, symptoms can strike infants quickly and unexpectedly, causing health crises that could have been prevented by early testing and treatment. As new panels for genetic conditions are developed, Delaware’s Newborn Screening Advisory Committee needs to evaluate the state’s regulations to ensure that every newborn has timely access to potentially lifesaving care.
Building on this need for screening, lawmakers should also capitalize on biomarker testing’s potential to improve diagnostics and the delivery of specialized care to the rare-disease community. Delaware Senate Bill 120, which was introduced last May, aims to guarantee that these tests are covered by individual, group, state employee and public assistance policies in Delaware. When interviewed, Sen. Spiros Mantzavinos, D-Elsmere, who sponsors the bill, emphasized that “tests like these can save families an emotional burden and lower long-term costs,” by facilitating timely diagnoses and tailored treatment for those with genetic diseases.
But, beyond specific legislation, raising awareness will ultimately be crucial to ensure that the needs of those with rare diseases are fully addressed. The difficulties that these individuals experience as they navigate their conditions demand that a compassionate, informed and responsive community rises to meet them, no less than any other health care concern does. When asked about the Rare Disease Advisory Council’s work, founding member and state Sen. Nicole Poore, D-New Castle, asserted that “it’s important that everybody — patients, scientists, advocates, insurers and legislators — unite to address the needs of their fellow Delawareans.” As Delaware marks Rare Disease Day, the struggles of those with rare disorders demand a statewide commitment to advocacy, awareness and compassion, so no condition goes overlooked and every Delawarean’s needs are met with the attention they deserve.
Be First to Comment